TRCT
IEIH

Tower Research Capital (TRC)’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Tower Research Capital (TRC)’s Portfolio IEIH Stock Details IEIH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-52,874
Closed -$1.74M – 6918
2022
Q2 		$1.74M Buy
52,874
+25,543
+93% +$838K 0.04% 418
2022
Q1 		$936K Buy
27,331
+13,225
+94% +$437K 0.01% 815
2021
Q4 		$500K Sell
14,106
-25,153
-64% -$878K 0.01% 1116
2021
Q3 		$1.38M Buy
39,259
+12,496
+47% +$453K 0.04% 383
2021
Q2 		$937K Buy
26,763
+7,940
+42% +$265K 0.02% 709
2021
Q1 		$609K Buy
+18,823
New +$627K 0.01% 1073
2020
Q4 		– Sell
-31,913
Closed -$965K – 5525
2020
Q3 		$965K Buy
31,913
+26,791
+523% +$812K 0.01% 1032
2020
Q2 		$153K Buy
+5,122
New +$147K 0.01% 2054
2020
Q1 		– Sell
-15,394
Closed -$430K – 4238
2019
Q4 		$430K Sell
15,394
-3,958
-20% -$104K 0.04% 307
2019
Q3 		$468K Buy
19,352
+421
+2% +$10.4K 0.03% 591
2019
Q2 		$483K Buy
+18,931
New +$474K 0.03% 475

Tower Research Capital (TRC)'s IEIH Position: Q3 2022 in Review

Tower Research Capital (TRC) sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 52,874 shares — an estimated $1.74M sold.

Tower Research Capital (TRC) first reported a position in IEIH in Q2 2019 and held it in 11 quarters. The position peaked at $1.74M in Q2 2022. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

  • Tower Research Capital (TRC) reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 52,874 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $1.74M.
  • Tower Research Capital (TRC) first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q2 2019 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s iShares Evolved U.S. Innovative Healthcare ETF position peaked at $1.74M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.